Market cap
$553.5B
Price as of
2026-10-29
Latest filing
8-K · 2026-09-23
Alerts
8
Price$130.03 +6.88% 3M daily closessample
133.67120.38
2026-08-032026-08-252026-09-162026-10-072026-10-29
purchase / approvalsale / rejectionfiling / neutral
Latest events
Filings, trades, FDA; newest first- Oct 27INS
- Oct 16INS
- Oct 12INS
- Oct 01INS
- Sep 28INS
- Sep 23SEC
- Sep 14INS
- Sep 07SEC
Company facts
SEC EDGAR registration- Name
- PolyPid Ltd.
- Sector
- Healthcare
- Industry
- Biotechnology
- Smart-money score
- +41sample, -100 to +100
- Reporting currency
- USD
Who is positioning in PYPD
sample- Insiders
- 18 insider transactions over 90 days, net selling, $489.6M
- Congress
- No member trades over 90 days
- Institutions · 13F
- 12 funds hold $10.5B
- Activists · 13D/G
- No 13D/13G activist filings on record
How are the fundamentals trending?
sample, by period endRevenue$33.3B +14.2% y/y
Q4 2024Q3 2026
Inventory$19.5B +11.7% y/y
Q4 2024Q3 2026
Accounts receivable$14.7B +14.9% y/y
Q4 2024Q3 2026
Total debt$39.5B +14.0% y/y
Q4 2024Q3 2026
Peers
sample- Sample peer A
- $435.4B +13.6% 3M
- Sample peer B
- $192.4B -0.0% 3M
- Sample peer C
- $95.8B +0.4% 3M
- Sample peer D
- $409.1B -3.4% 3M
- Sample peer E
- $488.9B -1.0% 3M